JESSE G. M. BULLOWA, M.D., F.A.C.P.; NATHAN H. SHACKMAN, M.D.; DANIEL STATS, M.D.
In the selection and application of our available resources for the treatment of pneumonias, we should be guided by consideration of the interaction of pneumococci and patients and the effect of our remedies on both. Final judgment must be based on clinical experience with adequately sized similar groups of patients treated with various therapies. Patients who completely recover from pneumonia without benefit of specific therapies do so by reason of their immunity response which completely destroys the invading bacteria; and such patients as a rule exhibit acquired immunity to the invading organism. Accordingly, the capacity to overcome infection, which is
Learn more about subscription options.
Register Now for a free account.
BULLOWA JGM, SHACKMAN NH, STATS D. CHEMOTHERAPY OF PNEUMONIAS AND IMMUNITY REACTIONS(CHEMOTHERAPY OF PNEUMONIAS AND IMMUNITY REACTIONS*). Ann Intern Med. 1942;16:57–70. doi: 10.7326/0003-4819-16-1-57
Download citation file:
Published: Ann Intern Med. 1942;16(1):57-70.
Infectious Disease, Pneumonia, Pulmonary/Critical Care.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only